251 related articles for article (PubMed ID: 15343182)
1. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
Chen CY; Tsao PN; Chen HL; Chou HC; Hsieh WS; Chang MH
J Pediatr; 2004 Sep; 145(3):317-21. PubMed ID: 15343182
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants.
Salvador A; Janeczko M; Porat R; Sekhon R; Moewes A; Schutzman D
J Pediatr; 2012 Aug; 161(2):229-33.e1. PubMed ID: 22424948
[TBL] [Abstract][Full Text] [Related]
4. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of parenteral nutrition-associated cholestasis with aminosyn PF compared to trophamine.
Wright K; Ernst KD; Gaylord MS; Dawson JP; Burnette TM
J Perinatol; 2003 Sep; 23(6):444-50. PubMed ID: 13679929
[TBL] [Abstract][Full Text] [Related]
6. Preterm small for gestational age infants are not at higher risk for parenteral nutrition-associated cholestasis.
Costa S; Maggio L; Sindico P; Cota F; De Carolis MP; Romagnoli C
J Pediatr; 2010 Apr; 156(4):575-9. PubMed ID: 20036379
[TBL] [Abstract][Full Text] [Related]
7. Parenteral nutrition-associated cholestasis in small for gestational age infants.
Robinson DT; Ehrenkranz RA
J Pediatr; 2008 Jan; 152(1):59-62. PubMed ID: 18154901
[TBL] [Abstract][Full Text] [Related]
8. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
[TBL] [Abstract][Full Text] [Related]
9. Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants.
Simić D; Milojević I; Bogićević D; Milenović M; Radlović V; Drasković B; Benka AU; Sindjić S; Maksimović R
Srp Arh Celok Lek; 2014; 142(3-4):184-8. PubMed ID: 24839773
[TBL] [Abstract][Full Text] [Related]
10. [Factors derived from parenteral nutrition associated with cholestasis in 612 neonates].
Tang QY; Wang Y; Feng Y; Tao YX; Wu J; Cai W
Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):838-42. PubMed ID: 18282416
[TBL] [Abstract][Full Text] [Related]
11. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.
Willis TC; Carter BA; Rogers SP; Hawthorne KM; Hicks PD; Abrams SA
JPEN J Parenter Enteral Nutr; 2010; 34(1):32-7. PubMed ID: 19587385
[TBL] [Abstract][Full Text] [Related]
12. Ursodiol in patients with parenteral nutrition-associated cholestasis.
San Luis VA; Btaiche IF
Ann Pharmacother; 2007 Nov; 41(11):1867-72. PubMed ID: 17911205
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for parenteral nutrition-associated cholestasis in preterm infants].
Li YH; Wang XL
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):254-8. PubMed ID: 23607945
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Dual-Center Study of Parenteral Nutrition-Associated Cholestasis in Premature Neonates: 15 Years' Experience.
Yan W; Hong L; Wang Y; Feng Y; Lu L; Tao Y; Wu J; Ruan H; Tang Q; Cai W
Nutr Clin Pract; 2017 Jun; 32(3):407-413. PubMed ID: 28135431
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
Gokmen T; Oguz SS; Bozdag S; Erdeve O; Uras N; Dilmen U
J Perinatol; 2012 Feb; 32(2):123-8. PubMed ID: 21566568
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid prevention on cholestasis associated with total parenteral nutrition in preterm infants: a randomized trial.
Liu SY; Chang LW; Wang J; Xie M; Chen LL; Liu W
World J Pediatr; 2022 Feb; 18(2):100-108. PubMed ID: 34988851
[TBL] [Abstract][Full Text] [Related]
17. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
18. [High-risk factors for parenteral nutrition-associated cholestasis in very low birth weight infants].
Zhu MY; Gu MZ
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):733-6. PubMed ID: 23092562
[TBL] [Abstract][Full Text] [Related]
19. Enteral fish oil supplementation in the resolution of parenteral nutrition associated cholestasis.
Thavamani A; Mhanna MJ; Groh-Wargo S; Gulati R; Shekhawat PS
J Neonatal Perinatal Med; 2019; 12(1):13-20. PubMed ID: 30373963
[TBL] [Abstract][Full Text] [Related]
20. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
